In clinical studies, elevated plasma and urinary IL-18 levels were associated with diabetic nephropathy, and IL-18 was observed to be a predictive marker for the development of diabetic nephropathy in diabetic patients and to be associated with the progression of renal dysfunction (106–108). Here, IL18 is linked to diabetic kidney disease.